Economic footprint IP Pharma by numbers Sustainable innovation Value of innovation
lest vppn
Value of innovation
电脑上vp Biotherapeutic medicines Falsified medicines Import testing Pharma by numbers Pharmacovigiliance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain 灯塔党建在线客户端电脑版|灯塔党建在线电脑版 V2.0.2830 ...:2021-8-23 · 灯塔党建在线电脑版是一款可伍让用户在电脑上进行党的建设发展学习的软件。软件落实全面从严治党要求,按照“党建宣传新阵地、工作交流新平台、教育管理新载体、凝聚力量新渠道、信息收集新方式,有需要的朋友可伍下载体验下。 The ARN: Le réseau africain de réglementation pharmaceutique
lest vppn
Pharmacovigiliance
IFPMA Code of Practice (2023) Our Ethos Code eLearning Tool IFPMA Complaint Operating Procedure How to File a Code Complaint 电脑上vp Complaint Submission Form Consensus Framework for Ethical Collaboration
lest vppn
IFPMA Code of Practice (2023)
Access to medicines Health technology assessment IP Pharma by numbers Trade
lest vppn
电脑vp软件
求推荐一个免费的vp Antimicrobial resistance Cancer Child and maternal health Diabetes Do you mind? campaign Ebola Falsified medicines Health partnerships 求推荐一个免费的vp Humanitarian and disaster relief aid Influenza vaccine Malaria 一个全屏手写标注软件,平板电脑特有用-专业指导 ...-CSDN下载:2021-11-3 · 本软件主要在电脑上做讲解标注,教师讲课特有用,尤其平板电脑太有用了更多下载资源、学习资料请访问CSDN下载频道. 求推荐一个免费的vp Non-communicable diseases 电脑vp软件 Pandemic influenza preparedness Pharma by numbers 电脑怎么开启vp 电脑vp软件 Seasonal influenza Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccines innovation Vaccines protect communities Vaccines sustainability 电脑vp软件 求推荐一个免费的vp Workplace wellness Zika Virus
lest vppn
Universal Health Coverage
IFPMA members commit to accelerate their effort to use their skills, technology and resources to bring safe, effective diagnostics, treatments and vaccines to patients around the world. Visit IFPMA COVID-19 Hub.
resources
News Releases
AMR Action Fund
More than 20 leading pharmaceutical companies launched a ground-breaking collective venture - the AMR Action Fund - to bridge the current gap in funding for the development of new antibiotics
Read More
COVID-19
IFPMA members commit to accelerate their effort to use their skills, technology and resources to bring safe, effective diagnostics, treatments and vaccines to patients around the world. Visit IFPMA COVID-19 Hub.
Read More
Global Biopharma CEO/Top Executives COVID-19 Media Briefing (28 May 2023)
On 28 May 2023, IFPMA organised a media briefing on the status of collaboration and risk-sharing to speed up the research, development and manufacturing of vaccines against COVID-19.
Watch more
求推荐一个免费的vp
On 30 April 2023, the global biopharmaceutical industry, represented by high-level executives/ CEO’s, took part in a virtual media briefing on the status of COVID-19 treatments
Watch more
Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing
On 19 March 2023, the global biopharmaceutical industry, represented by high-level executives/ CEO’s, took part in a virtual media briefing highlighting industry’s efforts and future commitments to address the current global coronavirus (COVID-19) crisis.
Watch more
resources
Publications
Collaborating to End Neglected Tropical Diseases
Progress has been significant in the fight against NTDs since the signing of the London Declaration in 2012. Our industry has been engaged in innovative collaborative partnerships, showcased in our new joint publication.
Read more
resources
Publications
Meet #GenerationGavi
Over the past 20 years, IFPMA and its members have proudly worked with Gavi, The Vaccine Alliance, to protect the most valuable resource on earth thanks to life saving vaccines: its children.
Read More
IFPMA Code of Practice eLearning
Our Code of Practice has evolved over time and it promotes a culture grounded on values, principles and decisions based on good judgement. You can take our new eLearning here!
Start training here
电脑怎么开启vpNext
lest vppn
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
电脑上vp
PreviousNext
lest vppn
FEATURED RESOURCES : Publications
IFPMA Code of Practice 2023
Read More
OTHER RESOURCES : Publications
Memorandum of Understanding between IFPMA and WADA (2023)
Read More
IFPMA Notes for Guidance
Read More
FEATURED RESOURCES : Infographics
Health for All in Africa - Our collaborations supporting the SDGs
IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
Geneva, 24 April 2023 Statement delivered by: Thomas Cueni, Director General, IFPMA The biopharmaceutical industry is acutely aware of the enormous responsibility we have to patients and society to engage in unprecedented levels of collaboration to find a solution to COVID-19. We stand ready to bring to this partnership our...
Read More
OTHER RESOURCES : Statements
IFPMA Statement - Access to COVID-19 Tools Accelerator (ACT-Accelerator) Investment Case
Read More
Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2023
On 24 July, Thomas Cueni, IFPMA Director General, joined Imogen Foulkes for the Inside Geneva podcast on Swiss Info, to talk about the development, production and eventual distribution of COVID-19 vaccines. Their discussion highlighted the importance of broad-based collaborative efforts among all stakeholders as well as the vital necessity of leaving no one behind and prioritizing the most vulnerable worldwide. However, in this race against...
Read More
30 Jul 2023
Chatham House: Weekly COVID-19 Pandemic Briefing – Perspective from the Pharmaceutical Industry
By Thomas B. Cueni
Published on Thomas Cueni’s LinkedIn profile. Last Wednesday, I sat down with @Chatham House’s @Emma Ross (moderator) and epidemiologist Professor @David L. Heymann to discuss the latest science and developments in the #COVID19 pandemic. During the interview, we discussed how the pharmaceutical industry is collaborating on an unprecedented scale to develop COVID-19 technologies and tools, the challenges and concerns the industry faces and the best approaches...
Read More
2 Jul 2023
Reinforcing Business Integrity for APEC Health Systems Amidst COVID-19
By Thomas B. Cueni
Authors: Dr. Jeff Blackmer, Mr. Thomas Cueni, Mr. Gaston Fernandez, Ms. Nancy Travis, Mr. Russell Williams The dual health and economic crisis resulting from COVID-19 has brought into sharp focus the importance of ethical business conduct. Emergency government measures, widespread economic and social disruption, as well as unscrupulous actors taking advantage of the current situation for personal gain are testing business integrity for SMEs and...
电脑上vp
PreviousNext
lest vppn
The onset of #COVID19 has devastated #immunization programs, leaving huge number of children unprotected from deadl… http://t.co/k6CKZbpcnl
1
-
August 3, 2023
Vaccines typically take years, if not decades, to reach people. @DrewQJoseph explains what has propelled efforts on… http://t.co/dYA3pB5ptG
-
August 3, 2023
Great discussion on challenges around 电脑怎么开启vp vaccines. One key message is around maintaining high levels of publi… 求推荐一个免费的vp